Literature DB >> 3661172

Risk factors for wheezing during infancy. A study of 5,953 infants.

H Bisgaard1, P Dalgaard, J Nyboe.   

Abstract

Risk factors for the development of wheezing during infancy were studied in 5,953 children. The data for the study were collected from a large prospective investigation of children born in 1959-61, who had attended a one-year follow-up examination. Wheezing was diagnosed when the symptom had been observed at least once during the first year of life, not in conjunction with pneumonia, epiglottitis or acute laryngitis. Logit analysis was used for the purpose of assessing the causal effect of environmental and other factors on the risk of wheezing among infants. The assessment of a risk factor by means of regression technique, requires certain other variables to be included in the regression model. A general rule concerning inclusion of other variables has been formulated and applied to the above data. The study demonstrated that the risk of wheezing was affected by a number of factors--particularly environmental. Poor social environment increases the risk of wheezing, as does the mother's smoking, and placement of the baby in day-care. Boys experienced wheezing more often than girls. Premature infants are more liable to develop wheezing than mature children. Remarkably, children born in the period April through September develop wheezing, but not bronchitis, more often than children born in October through March.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3661172     DOI: 10.1111/j.1651-2227.1987.tb10555.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  11 in total

1.  Measuring environmental tobacco smoke exposure in infants and young children through urine cotinine and memory-based parental reports: empirical findings and discussion.

Authors:  G E Matt; D R Wahlgren; M F Hovell; J M Zakarian; J T Bernert; S B Meltzer; J L Pirkle; S Caudill
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

2.  Atopy, bronchial responsiveness, and symptoms in wheezy 3 year olds.

Authors:  N M Wilson; S B Phagoo; M Silverman
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

3.  Respiratory Effects of Passive Smoking: Discovering the effects of environmental cigarette smoke.

Authors:  R J Shephard
Journal:  Can Fam Physician       Date:  1991-04       Impact factor: 3.275

4.  Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood.

Authors:  D P Strachan; D G Cook
Journal:  Thorax       Date:  1997-10       Impact factor: 9.139

5.  Food and drug reactions, wheezing, and eczema in preterm infants.

Authors:  A Lucas; O G Brooke; T J Cole; R Morley; M F Bamford
Journal:  Arch Dis Child       Date:  1990-04       Impact factor: 3.791

6.  Early diet of preterm infants and development of allergic or atopic disease: randomised prospective study.

Authors:  A Lucas; O G Brooke; R Morley; T J Cole; M F Bamford
Journal:  BMJ       Date:  1990-03-31

7.  Parental and neonatal risk factors for atopy, airway hyper-responsiveness, and asthma.

Authors:  M R Sears; M D Holdaway; E M Flannery; G P Herbison; P A Silva
Journal:  Arch Dis Child       Date:  1996-11       Impact factor: 3.791

8.  Recurrent wheezy bronchitis and viral respiratory infections.

Authors:  J Mertsola; T Ziegler; O Ruuskanen; T Vanto; A Koivikko; P Halonen
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791

Review 9.  Parental and household smoking and the increased risk of bronchitis, bronchiolitis and other lower respiratory infections in infancy: systematic review and meta-analysis.

Authors:  Laura L Jones; Ahmed Hashim; Tricia McKeever; Derek G Cook; John Britton; Jo Leonardi-Bee
Journal:  Respir Res       Date:  2011-01-10

10.  Design and study protocol of the maternal smoking cessation during pregnancy study, (M-SCOPE).

Authors:  Andriani N Loukopoulou; Constantine I Vardavas; George Farmakides; Christos Rossolymos; Charalambos Chrelias; Manolis N Tzatzarakis; Aristidis Tsatsakis; Maria Lymberi; Gregory N Connolly; Panagiotis K Behrakis
Journal:  BMC Public Health       Date:  2011-12-06       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.